Pfizer Abandons Plans To Merge With Ireland’s Allergan

Pfizer has ditched its planned merger with Ireland’s Allergan following changes to US tax laws. The deal, valued at $160bn, would have been the biggest example of a so-called “inversion”, which would have seen Pfizer moving its corporate headquarters to

The full content of this article is restricted to NamNews Subscribers. If you are an existing user, please log in below. Forgotten your password? Any problems logging in, contact us

Existing Users Log In
 Remember Me